1-3 of 3
Salvatore Buffardi, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response-Adapted Therapy with Nivolumab and Brentuximab Vedotin (BV), Followed By BV and Bendamustine for Suboptimal Response, in Children, Adolescents, and Young Adults with Standard-Risk Relapsed/Refractory Classical Hodgkin Lymphoma

Paul Harker-Murray, MD PhD, Thierry Leblanc, MD, Maurizio Mascarin, Christine Mauz-Körholz, Gerard Michel, MD, Stacy Cooper, MD, Auke Beishuizen, MD PhD, Kasey J. Leger, MD MSc, Alberto Garaventa, Salvatore Buffardi, MD, Laurence Brugieres, MD, Kara M. Kelly, MD, Peter D. Cole, MD, Richard A. Drachtman, Faith Galderisi, DO, Mariana Sacchi, MD, Ying-Ming Jou, Stephen Daw
Journal: Blood
Blood (2018) 132 (Supplement 1): 927.
https://doi.org/10.1182/blood-2018-99-111279
Published: 2018
Journal Articles

Efficacy of Dasatinib to Treat Molecular Relapse in an Adolescent with Philadelphia-Positive Acute Lymphoblastic Leukemia

Fara Petruzziello, MD, Giovanna Giagnuolo, MD, Giuseppe Menna, MD, Giovanni Cazzaniga, PhD, Giada Muccioli Casadei, PhD, Salvatore Buffardi, MD, Giovanna Maisto, Rosanna Parasole, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5045.
https://doi.org/10.1182/blood.V130.Suppl_1.5045.5045
Published: 2017
Journal Articles

Brentuximab Vedotin in Combination with Bendamustine in Relapsed or Refractory Hodgkin Lymphoma: A Retrospective Analysis on 23 Paediatric Patients or Young Adults

Luciana Vinti, MD, Franco Locatelli, MD PhD, Pietro Merli, MD, Rosanna Parasole, MD, Salvatore Buffardi, MD, Marta Pillon, Luisa Strocchio, Katia Girardi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4090.
https://doi.org/10.1182/blood.V130.Suppl_1.4090.4090
Published: 2017